VEGFA and acute lymphoblastic leukemia: The results demonstrate that VEGF‐A, along with other angiogenic and inflammatory markers such as bFGF, PDGF, and IL‐6, serves as a valuable biomarker for diagnosis and prognosis in patients with ALL.